308 related articles for article (PubMed ID: 25792708)
1. A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis.
Miehlke S; Hruz P; Vieth M; Bussmann C; von Arnim U; Bajbouj M; Schlag C; Madisch A; Fibbe C; Wittenburg H; Allescher HD; Reinshagen M; Schubert S; Tack J; Müller M; Krummenerl P; Arts J; Mueller R; Dilger K; Greinwald R; Straumann A
Gut; 2016 Mar; 65(3):390-9. PubMed ID: 25792708
[TBL] [Abstract][Full Text] [Related]
2. Swallowed topical corticosteroids for eosinophilic esophagitis: Utilization and real-world efficacy from the EoE CONNECT registry.
Laserna-Mendieta EJ; Navarro P; Casabona-Francés S; Savarino EV; Amorena E; Pérez-Martínez I; Guagnozzi D; Blas-Jhon L; Betoré E; Guardiola-Arévalo A; Pellegatta G; Krarup AL; Perello A; Barrio J; Gutiérrez-Junquera C; Teruel Sánchez-Vegazo C; Fernández-Fernández S; Naves JE; Oliva S; Rodríguez-Oballe JA; Carrión S; Espina S; Llorente Barrio M; Masiques-Mas ML; Dainese R; Feo-Ortega S; Martín-Dominguez V; Fernández-Pacheco J; Pérez-Fernández MT; Ghisa M; Maniero D; Nantes-Castillejo Ó; Nicolay-Maneru J; Suárez A; Maray I; Llerena-Castro R; Ortega-Larrodé A; Alcedo J; Granja Navacerrada A; Racca F; Santander C; Arias Á; Lucendo AJ;
United European Gastroenterol J; 2024 Jun; 12(5):585-595. PubMed ID: 38284792
[TBL] [Abstract][Full Text] [Related]
3. Pooled Phase 2 and 3 Efficacy and Safety Data on Budesonide Oral Suspension in Adolescents with Eosinophilic Esophagitis.
Mukkada VA; Gupta SK; Gold BD; Dellon ES; Collins MH; Katzka DA; Falk GW; Williams J; Zhang W; Boules M; Hirano I; Desai NK
J Pediatr Gastroenterol Nutr; 2023 Dec; 77(6):760-768. PubMed ID: 37718471
[TBL] [Abstract][Full Text] [Related]
4. Swallowed topical steroid therapy for eosinophilic oesophagitis in children: practical, evidence-based guidance by the BSPGHAN Eosinophilic Oesophagitis Working Group.
Chan J; Flynn DM; Gordon M; Parmar R; Moolenschot K; Jackman L; Gaynor E; Epstein J; Cordell A; Kannappan H; Furman M; Thompson J; Gasparetto M; Auth MKH
BMJ Paediatr Open; 2024 May; 8(1):. PubMed ID: 38782481
[TBL] [Abstract][Full Text] [Related]
5. Novel corticosteroid formulations in the treatment of eosinophilic esophagitis: what is the evidence?
Walgraeve S; Vanuytsel T
Acta Gastroenterol Belg; 2023; 86(3):437-448. PubMed ID: 37814560
[TBL] [Abstract][Full Text] [Related]
6. Budesonide oral suspension (Eohilia) for eosinophilic esophagitis.
Med Lett Drugs Ther; 2024 Jun; 66(1704):93-95. PubMed ID: 38905533
[No Abstract] [Full Text] [Related]
7. Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence.
Miehlke S; Lucendo AJ; Straumann A; Jan Bredenoord A; Attwood S
Therap Adv Gastroenterol; 2020; 13():1756284820927282. PubMed ID: 32565912
[TBL] [Abstract][Full Text] [Related]
8. Comparison of drugs for active eosinophilic oesophagitis: systematic review and network meta-analysis.
Visaggi P; Barberio B; Del Corso G; de Bortoli N; Black CJ; Ford AC; Savarino E
Gut; 2023 Nov; 72(11):2019-2030. PubMed ID: 37491157
[TBL] [Abstract][Full Text] [Related]
9. Mucoadhesive Budesonide Solution for the Treatment of Pediatric Eosinophilic Esophagitis.
Spennacchio A; Lopalco A; Racaniello GF; Cutrignelli A; la Forgia FM; Fontana S; Cristofori F; Francavilla R; Lopedota AA; Denora N
Pharmaceuticals (Basel); 2024 Apr; 17(5):. PubMed ID: 38794121
[TBL] [Abstract][Full Text] [Related]
10. Comparing the relative efficacy of therapeutics for eosinophilic oesophagitis: is counting eosinophils the right target?
Hirano I; Katzka D
Gut; 2023 Nov; 72(11):2007-2008. PubMed ID: 37709491
[No Abstract] [Full Text] [Related]
11. Budesonide Irrigation-Induced Mania in an Elderly Woman.
Luzum NR; Agrawal H
Prim Care Companion CNS Disord; 2023 Sep; 25(5):. PubMed ID: 37788805
[No Abstract] [Full Text] [Related]
12. An important step towards the long-term treatment of eosinophilic oesophagitis.
Marabotto E; Savarino EV
Lancet Gastroenterol Hepatol; 2023 Nov; 8(11):957-959. PubMed ID: 37660706
[No Abstract] [Full Text] [Related]
13. Budesonide Oral Suspension Improves Symptomatic, Endoscopic, and Histologic Parameters Compared With Placebo in Patients With Eosinophilic Esophagitis.
Dellon ES; Katzka DA; Collins MH; Hamdani M; Gupta SK; Hirano I;
Gastroenterology; 2017 Mar; 152(4):776-786.e5. PubMed ID: 27889574
[TBL] [Abstract][Full Text] [Related]
14. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults.
Lucendo AJ; Molina-Infante J; Arias Á; von Arnim U; Bredenoord AJ; Bussmann C; Amil Dias J; Bove M; González-Cervera J; Larsson H; Miehlke S; Papadopoulou A; Rodríguez-Sánchez J; Ravelli A; Ronkainen J; Santander C; Schoepfer AM; Storr MA; Terreehorst I; Straumann A; Attwood SE
United European Gastroenterol J; 2017 Apr; 5(3):335-358. PubMed ID: 28507746
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Proton Pump Inhibitor Drugs for Inducing Clinical and Histologic Remission in Patients With Symptomatic Esophageal Eosinophilia: A Systematic Review and Meta-Analysis.
Lucendo AJ; Arias Á; Molina-Infante J
Clin Gastroenterol Hepatol; 2016 Jan; 14(1):13-22.e1. PubMed ID: 26247167
[TBL] [Abstract][Full Text] [Related]
16. Topical steroids in eosinophilic esophagitis: Systematic review and meta-analysis of placebo-controlled randomized clinical trials.
Murali AR; Gupta A; Attar BM; Ravi V; Koduru P
J Gastroenterol Hepatol; 2016 Jun; 31(6):1111-9. PubMed ID: 26699695
[TBL] [Abstract][Full Text] [Related]
17. Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference.
Dellon ES; Liacouras CA; Molina-Infante J; Furuta GT; Spergel JM; Zevit N; Spechler SJ; Attwood SE; Straumann A; Aceves SS; Alexander JA; Atkins D; Arva NC; Blanchard C; Bonis PA; Book WM; Capocelli KE; Chehade M; Cheng E; Collins MH; Davis CM; Dias JA; Di Lorenzo C; Dohil R; Dupont C; Falk GW; Ferreira CT; Fox A; Gonsalves NP; Gupta SK; Katzka DA; Kinoshita Y; Menard-Katcher C; Kodroff E; Metz DC; Miehlke S; Muir AB; Mukkada VA; Murch S; Nurko S; Ohtsuka Y; Orel R; Papadopoulou A; Peterson KA; Philpott H; Putnam PE; Richter JE; Rosen R; Rothenberg ME; Schoepfer A; Scott MM; Shah N; Sheikh J; Souza RF; Strobel MJ; Talley NJ; Vaezi MF; Vandenplas Y; Vieira MC; Walker MM; Wechsler JB; Wershil BK; Wen T; Yang GY; Hirano I; Bredenoord AJ
Gastroenterology; 2018 Oct; 155(4):1022-1033.e10. PubMed ID: 30009819
[TBL] [Abstract][Full Text] [Related]
18. Adrenal Insufficiency after Chronic Swallowed Glucocorticoid Therapy for Eosinophilic Esophagitis.
Golekoh MC; Hornung LN; Mukkada VA; Khoury JC; Putnam PE; Backeljauw PF
J Pediatr; 2016 Mar; 170():240-5. PubMed ID: 26687577
[TBL] [Abstract][Full Text] [Related]
19. Retrospective Comparison of Fluticasone Propionate and Oral Viscous Budesonide in Children With Eosinophilic Esophagitis.
Fable JM; Fernandez M; Goodine S; Lerer T; Sayej WN
J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):26-32. PubMed ID: 28489670
[TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of Budesonide Oral Suspension Maintenance Therapy in Patients With Eosinophilic Esophagitis.
Dellon ES; Katzka DA; Collins MH; Gupta SK; Lan L; Williams J; Hirano I
Clin Gastroenterol Hepatol; 2019 Mar; 17(4):666-673.e8. PubMed ID: 29902649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
